255 related articles for article (PubMed ID: 36114030)
21. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.
Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S
Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563
[TBL] [Abstract][Full Text] [Related]
22. Uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma.
Kubo T; Sugita S; Wada R; Kikuchi N; Iwasaki M; Ito Y; Sugawara T; Fujita H; Emori M; Tanaka R; Hirano H; Saito T; Hasegawa T
Diagn Pathol; 2017 Mar; 12(1):26. PubMed ID: 28288693
[TBL] [Abstract][Full Text] [Related]
23. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR
Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955
[TBL] [Abstract][Full Text] [Related]
24. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
[TBL] [Abstract][Full Text] [Related]
25. Endometrial stromal sarcoma of uterus.
Xue WC; Cheung AN
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):719-32. PubMed ID: 21820965
[TBL] [Abstract][Full Text] [Related]
26. Uterine sarcomas: clinical presentation and MRI features.
Santos P; Cunha TM
Diagn Interv Radiol; 2015; 21(1):4-9. PubMed ID: 25347940
[TBL] [Abstract][Full Text] [Related]
27. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.
Lewis N; Soslow RA; Delair DF; Park KJ; Murali R; Hollmann TJ; Davidson B; Micci F; Panagopoulos I; Hoang LN; Arias-Stella JA; Oliva E; Young RH; Hensley ML; Leitao MM; Hameed M; Benayed R; Ladanyi M; Frosina D; Jungbluth AA; Antonescu CR; Chiang S
Mod Pathol; 2018 Apr; 31(4):674-684. PubMed ID: 29192652
[TBL] [Abstract][Full Text] [Related]
28. SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study.
Le Page C; Almadani N; Turashvili G; Bataillon G; Portelance L; Provencher D; Mes-Masson AM; Gilks B; Hoang L; Rahimi K
Int J Gynecol Pathol; 2021 Sep; 40(5):487-494. PubMed ID: 33720083
[TBL] [Abstract][Full Text] [Related]
29. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
[TBL] [Abstract][Full Text] [Related]
30. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
Chiang S; Lee CH; Stewart CJR; Oliva E; Hoang LN; Ali RH; Hensley ML; Arias-Stella JA; Frosina D; Jungbluth AA; Benayed R; Ladanyi M; Hameed M; Wang L; Kao YC; Antonescu CR; Soslow RA
Mod Pathol; 2017 Sep; 30(9):1251-1261. PubMed ID: 28621321
[TBL] [Abstract][Full Text] [Related]
31. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors.
Oliva E; Clement PB; Young RH
Int J Gynecol Pathol; 2002 Jan; 21(1):48-55. PubMed ID: 11781523
[TBL] [Abstract][Full Text] [Related]
32. Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors.
Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
Hum Pathol; 2021 Oct; 116():12-21. PubMed ID: 34271067
[TBL] [Abstract][Full Text] [Related]
33. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype.
Oliva E; Clement PB; Young RH
Adv Anat Pathol; 2000 Sep; 7(5):257-81. PubMed ID: 10976906
[TBL] [Abstract][Full Text] [Related]
34. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
[TBL] [Abstract][Full Text] [Related]
35. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
36. Clinical management of uterine sarcomas.
Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
[TBL] [Abstract][Full Text] [Related]
37. Role of the Immunohistochemical ZEB1 Expression in Uterine Mesenchymal Neoplasms.
Çelik M; Çelik ZE
Int J Surg Pathol; 2022 Aug; 30(5):520-527. PubMed ID: 34994578
[TBL] [Abstract][Full Text] [Related]
38. Staging of uterine sarcomas.
Tse KY; Crawford R; Ngan HY
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
[TBL] [Abstract][Full Text] [Related]
39. Microsatellite instability in uterine sarcomas.
Amant F; Dorfling CM; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
Int J Gynecol Cancer; 2001; 11(3):218-23. PubMed ID: 11437928
[TBL] [Abstract][Full Text] [Related]
40. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]